Adaptive Biotechnologies ADPT Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's gross profit?
- Adaptive Biotechnologies (ADPT) reported gross profit of $52.17M in Q1 2026.
- How has Adaptive Biotechnologies's gross profit changed year-over-year?
- Adaptive Biotechnologies's gross profit increased by 47.1% year-over-year, from $35.46M to $52.17M.
- What is the long-term trend for Adaptive Biotechnologies's gross profit?
- Over 4 years (2021 to 2025), Adaptive Biotechnologies's gross profit has grown at a 18.3% compound annual growth rate (CAGR), from $105.04M to $205.62M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.